We are live on ! Find out more
TECH icon

Bio-Techne

248 hedge funds and large institutions have $2.6B invested in Bio-Techne in 2013 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 98 increasing their positions, 87 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 17

20% more capital invested

Capital invested by funds: $2.17B → $2.6B (+$430M)

13% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 87

6% more funds holding

Funds holding: 233248 (+15)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
248
Holders Change
+15
Holders Change %
+6.44%
% of All Funds
8.04%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
34
Increased
98
Reduced
87
Closed
17
Calls
$88K
Puts
Net Calls
+$88K
Net Calls Change
+$102K
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$28.3M +$226K +11,896 +0.8%
MIH
27
Madison Investment Holdings
Wisconsin
$27.2M -$7.94M -418,264 -24%
Northern Trust
28
Northern Trust
Illinois
$26.9M -$611K -32,184 -2%
ACM
29
Atlanta Capital Management
Georgia
$24.6M +$764K +40,284 +3%
O
30
OrbiMed
New York
$21.3M +$13.7M +720,000 +209%
Norges Bank
31
Norges Bank
Norway
$19.8M +$6M +316,172 +47%
CIP
32
Champlain Investment Partners
Vermont
$19.7M -$17.5M -920,920 -48%
MAA
33
Managed Account Advisors
New Jersey
$16.7M -$212K -11,196 -1%
Ameriprise
34
Ameriprise
Minnesota
$16.6M +$3.87M +203,728 +33%
SBH
35
Segall Bryant & Hamill
Illinois
$16M +$14.9M +786,488 +6,554%
SAM
36
Sentinel Asset Management
Vermont
$15.9M -$4.35M -229,200 -22%
Citadel Advisors
37
Citadel Advisors
Florida
$15.8M -$4.05M -213,224 -21%
EAM
38
Edge Asset Management
Washington
$13.2M +$6.57M +346,144 +96%
Geode Capital Management
39
Geode Capital Management
Massachusetts
$12.7M +$570K +30,016 +5%
SIMG
40
Stephens Investment Management Group
Texas
$12.6M +$4.3M +226,580 +56%
AI
41
Analytic Investors
California
$12.5M +$138K +7,272 +1%
TCIM
42
TIAA CREF Investment Management
New York
$12M +$404K +21,276 +4%
CCA
43
Conestoga Capital Advisors
Pennsylvania
$11.7M -$11K -580 -0.1%
Prudential Financial
44
Prudential Financial
New Jersey
$11.7M +$2.13M +112,056 +24%
RFC
45
Russell Frank Company
Washington
$10.9M +$5.53M +291,192 +116%
AL
46
AJO LP
Pennsylvania
$10.6M -$121K -6,400 -1%
GCM
47
Geneva Capital Management
Wisconsin
$10.6M +$1.32M +69,776 +15%
Fidelity International
48
Fidelity International
Bermuda
$8.79M +$8.33M +439,200 New
HCM
49
Highbridge Capital Management
New York
$8.75M +$701K +36,932 +9%
RCMC
50
RK Capital Management (Colorado)
Colorado
$8.35M +$7.92M +417,200 New

TECH Hedge Fund Activity: Q3 2013 in Review

248 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2013, worth a combined $2.6B — up 20% from $2.17B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new TECH positions and 17 closed out — a net gain of 17 holders — while 98 added to existing stakes and 87 trimmed.

The largest buyer was Schroder Investment Management Group, adding an estimated $27.2M. The largest seller was Champlain Investment Partners, cutting an estimated $17.5M.

  • 248 institutional investors held Bio-Techne (TECH) as of Q3 2013, up from 233 in Q2 2013.
  • Funds reported $2.6B of Bio-Techne stock for Q3 2013, up 20% quarter-over-quarter.
  • 34 funds opened new Bio-Techne positions in Q3 2013 and 17 closed out, a net change of +17 holders.
  • The largest Bio-Techne buyer in Q3 2013 was Schroder Investment Management Group, an estimated $27.2M added.
  • The largest Bio-Techne seller in Q3 2013 was Champlain Investment Partners, an estimated $17.5M sold.

Based on aggregated 13F filings for Q3 2013.